A Multicenter Double Blind Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar? Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis

Study Overview

The purpose of this study is to determine if adding Acthar to riluzole will further help by either slowing down how fast ALS symptoms progress and/or increasing the time before you die.

Study Description

The purpose of this study is to examine the effect of Acthar on decline in adult subjects with ALS.

Additional Information

Participants will be compensated for their participation.


  • IRB Number: 1703907333
  • Research Study Identifier: TX8017
  • Principal Investigator: Cynthia Bodkin, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176